American Urological Associaton Education and Research, Inc. – Trademark Portfolio

Entity Type: 03

American Urological Associaton Education and Research, Inc. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 41 (Education & Entertainment) — 1 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 2 Nice Classification classes. The owner is based in Linthicum Heights, MD.

1000 Corporate Blvd.

Linthicum Heights, MD 21090

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

American Urological Associaton Education and Research, Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

41
Education & Entertainment (1 filing)

Education; providing of training; entertainment; sporting and cultural activities

44
Medical Services (1 filing)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

Frequently Asked Questions

How many trademarks does American Urological Associaton Education and Research, Inc. have?

American Urological Associaton Education and Research, Inc. has 1 U.S. trademark filed with the USPTO.

What trademark classes does American Urological Associaton Education and Research, Inc. file in?

American Urological Associaton Education and Research, Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 41 (Education & Entertainment), Class 44 (Medical Services). Class 41 covers education; providing of training; entertainment; sporting and cultural activities.

What is American Urological Associaton Education and Research, Inc.'s trademark registration success rate?

American Urological Associaton Education and Research, Inc. has a 0% trademark registration rate, with 0 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.